Acadia Healthcare Company Business Summary

Acadia Healthcare Company, Inc. (ACHC) operates as the largest stand-alone behavioral healthcare provider in the United States, generating revenue through a fee-for-service model across four primary segments: acute inpatient psychiatric facilities, specialty treatment facilities for substance abuse and eating disorders, comprehensive treatment centers for opioid use disorder, and residential treatment centers. As of early 2026, the company’s revenue stream is heavily weighted toward government payers, with Medicaid and Medicare accounting for approximately 70% of total collections, while commercial insurance and self-pay comprise the remainder. Acadia differentiates itself through a robust joint-venture strategy with non-profit health systems, allowing it to scale capacity while mitigating the high startup costs associated with de novo facility development. Its primary direct competitors include Universal Health Services (UHS), Encompass Health, and Select Medical; within this landscape, Acadia maintains a dominant pure-play position in the behavioral sector, specifically leading the market in methadone-clinic operations and inpatient psychiatric bed count. Founded in 2005 by Reeve B. Waud and the private equity firm Waud Capital Partners, Acadia was built as a strategic platform to consolidate the fragmented behavioral health market. The leadership team is currently led by CEO Debra K. Osteen, a mission-driven executive with over 35 years of industry experience who returned to the role in January 2026 after previously serving as President of Universal Health Services’ behavioral division. She is supported by CFO Todd Young, who joined in late 2025 bringing significant pedigree from his tenure as CFO of Elanco Animal Health and ACADIA Pharmaceuticals. The company’s governance is anchored by Board Chairman Reeve B. Waud, whose firm provided the initial capital and strategic direction for the company’s 2011 IPO. Other notable board members include Vicky Gregg, former CEO of BlueCross BlueShield of Tennessee, and Jason R. Bernhard, a Managing Director at Lazard, reflecting a leadership team with deep expertise in healthcare operations, finance, and institutional growth.